KMPH

KemPharm Inc.

Price

return (12m)

p/e

-3.33

p/bv

2.40

DIVIDEND YIELD

0.00%

KMPH price

KemPharm

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment KMPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals KMPH

Valuation

P/E

-3.33

Sector -4.38

Industry -4.38

P/BV

2.40

Sector 2.02

Industry 2.02

P/Revenue (PSR)

18.28

Sector -4.40

Industry -4.40

EV/EBITDA

Sector -263.09

Industry -263.09

EV/EBIT

Sector -702.90

Industry -702.90

P/EBITDA

-3.47

Sector -4.39

Industry -4.39

P/EBIT

-3.40

Sector -4.73

Industry -4.73

P/Total Assets

1.61

Sector 1.49

Industry 1.49

P/Net Current Assets

Sector -11.70

Industry -11.70

P/Working Capital

Sector -3.19

Industry -3.19

EPS

-1.49

Sector -2.14

Industry -2.14

BVPS

2.07

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

95.09%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-418.62%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-421.36%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.03

Sector 0.03

Industry 0.03

Profitability

ROE

-72.05%

Sector -65.14%

Industry -65.14%

ROA

-48.26%

Sector -65.53%

Industry -65.53%

ROIC

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -6.07

Industry -6.07

Net Debt / EBIT

Sector -8.26

Industry -8.26

Net Debt / Equity

Sector -1.07

Industry -1.07

Gross Debt / Equity

Sector -0.05

Industry -0.05

Equity/Assets

0.67

Sector 0.41

Industry 0.41

Liabilities/Assets

0.67

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-20.03%

Sector -

Industry -

5Y Earnings CAGR

-3.94%

Sector -

Industry -

Fundamentals KMPH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
KMPH KemPharm Inc.	$0.00	-	0.00%	-3.33	2.40	-72.05%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

KMPH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT KemPharm

KemPharm Inc.

Average Investor10 user rating

4.0 (0 people)

United States

20 years

Founded: 2006

2015

Time since IPO - 11 years

22

Employees

KemPharm Inc. (United States) is listed on the Nasdaq and has a market capitalization of $171.30 million, with shareholders equity totaling $71.40 million.

The company employs approximately 22 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, KemPharm Inc. reported $9.37 million in revenue, generating net income of $-51.45 million.

Key financial metrics include a P/E ratio of -3.33, a price-to-book (P/B) ratio of 2.40, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker KMPH.

Market cap

$171.30 million

Net worth

$71.40 million

$71,404,000.00

Assets

$106.60 million

$106,595,000.00

Total Shares Outstanding

34.47 million

34,466,000

Average Daily Trading Volume

$256.89 Thousand

$256,890.14

Sector

Health Care

Industry

Biotechnology

KMPH

KMPH revenue and profits

Financial Results KMPH

DRAG THE FRAME TO SEE MORE DATA

KMPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of KemPharm (KMPH) today?

A cotação de KemPharm (KMPH) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de KemPharm (KMPH) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de KemPharm (KMPH) e dados de ações do Ibovespa e mercados internacionais.

Quando KemPharm (KMPH) paga dividendos?

KemPharm (KMPH) não distribuiu dividendos no último ano.

Is KemPharm (KMPH) a good investment?

Atualmente, KemPharm (KMPH) está cotada a US$ 0.00, com um P/L de -3.33, representando um desvio de -357% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy KemPharm (KMPH) stock?

Investir em ações de KemPharm (KMPH) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of KemPharm (KMPH) yield today?

A rentabilidade de KemPharm (KMPH) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de KemPharm (KMPH) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KMPH

KemPharm Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KMPH

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING KMPH WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT KemPharm

KemPharm Inc.

United States

20 years

2015

22

PROFIT X PRICE KMPH

Financial Results KMPH

KMPH cash flow

Asset, Revenue and Profit Growth - KMPH

KMPH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions